Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (181-190 of 427) with videos related to

Pageof 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2018
Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT StudyMarc Peeters, Timothy Price, Michael Boedigheimer, et al.
Cancers|May 7, 2020
[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 PatientsMarius E Mayerhoefer, Christopher C Riedl, Anita Kumar, et al.
Clinical Colorectal Cancer|May 15, 2025
Clinical Impact of Sub-Clonal RAS/BRAF Alterations in Liquid Biopsies From Patients With Advanced or Metastatic CRCPeter Gibbs, Khalid Abubaker, Danyi Wang, et al.
Critical Reviews in Oncology/Hematology|July 6, 2012
Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factorsStephen J Clarke, Christos S Karapetis, Peter Gibbs, et al.
Trials|February 7, 2023
"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and cliniciansKhic-Houy Prang, Bill Karanatsios, Angela Zhang, et al.
International Journal of Cancer|March 13, 2025
Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data studyAllison Drosdowsky, Karen E Lamb, Luc Te Marvelde, et al.
ANZ Journal of Surgery|March 8, 2024
Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patientsMatthew Y Wei, Ke Cao, Wei Hong, et al.
BMJ Open|December 9, 2024
Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysisOu Yang, Yuting Zhang, Yat Hang To, et al.
Acta Oncologica (Stockholm, Sweden)|December 30, 2020
Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohortSiavash Foroughi, Hui-Li Wong, Jeanne Tie, et al.
ANZ Journal of Surgery|March 23, 2011
Lymph node yield following colorectal cancer surgeryKathryn Field, Cameron Platell, Nicholas Rieger, et al.
Pageof 43

Showing results (181-190 of 427) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2018
Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT StudyMarc Peeters, Timothy Price, Michael Boedigheimer, et al.
Cancers|May 7, 2020
[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 PatientsMarius E Mayerhoefer, Christopher C Riedl, Anita Kumar, et al.
Clinical Colorectal Cancer|May 15, 2025
Clinical Impact of Sub-Clonal RAS/BRAF Alterations in Liquid Biopsies From Patients With Advanced or Metastatic CRCPeter Gibbs, Khalid Abubaker, Danyi Wang, et al.
Critical Reviews in Oncology/Hematology|July 6, 2012
Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factorsStephen J Clarke, Christos S Karapetis, Peter Gibbs, et al.
Trials|February 7, 2023
"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and cliniciansKhic-Houy Prang, Bill Karanatsios, Angela Zhang, et al.
International Journal of Cancer|March 13, 2025
Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data studyAllison Drosdowsky, Karen E Lamb, Luc Te Marvelde, et al.
ANZ Journal of Surgery|March 8, 2024
Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patientsMatthew Y Wei, Ke Cao, Wei Hong, et al.
BMJ Open|December 9, 2024
Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysisOu Yang, Yuting Zhang, Yat Hang To, et al.
Acta Oncologica (Stockholm, Sweden)|December 30, 2020
Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohortSiavash Foroughi, Hui-Li Wong, Jeanne Tie, et al.
ANZ Journal of Surgery|March 23, 2011
Lymph node yield following colorectal cancer surgeryKathryn Field, Cameron Platell, Nicholas Rieger, et al.
Pageof 43